De Novo Antibody Sequencing Case Study
Abterra Bio uses bioinformatics and mass spectrometry to reconstructs the full amino acid sequence of both antibody chains. We’ve successfully sequenced human, mouse, rat, hamster, rabbit, and llama antibodies. This approach can be applied across any species and isotype, including IgG’s and IgM’s.
Contact us to learn more about how our Valens™ de novo antibody sequencing can recover the full antibody sequence when no source cell is available!
![Valens Anti-FLAG M2 Case Study](https://abterrabio.com/wp-content/uploads/2021/09/Valens-Anti-FLAG-M2-Case-Study.jpg)
Tell Us About Your Project
Related Resources
For 100% sequence accuracy, antibody sequencing experience matters. Read our blog post to understand more about our service and why you would need de novo sequencing.
VHH Antibody Repertoire to Phage Library Comparison
Project Summary Camelids such as llamas and alpacas produce conventional antibodies as well as heavy-chain only antibodies (HCAbs) from which the small, stable antigen-binding domain (VHH) can be extracted. Abterra Biosciences developed Reptor, a proprietary antibody...
Case Study: Reptor Biological vs Technical Replicates
Project Summary Next-generation sequencing of B cell populations (Rep-Seq) has become a powerful tool in immunology and antibody discovery. At Abterra Bio we developed Reptor, an integrated Rep-Seq sequencing and analysis service. A key goal of Reptor is to provide...
Abterra Opens Its Doors To Celebrate New Location With Open House
Celebrating milestones is an important part of our personal and professional journeys. We wanted to commemorate this exciting new chapter in Abterra's story with the people who mean the most to us: our devoted employees, cherished families, esteemed investors, and...